Company · CIK 2044725
Evommune, Inc.
| CIK | 2044725 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | EVMN (NYSE) |
| First annual or quarterly report | 2025-12-11 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-295140 | 2026-04-17 | 2026-04-24 | 2 | |
| 333-290793 | 2025-10-09 | 2025-11-06 | 3 |
Filings
6| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-04-24 | EFFECTDeclared effective | 333-295140 | 9999999995-26-001330 |
| 2026-04-17 | S-1Registration filed | 333-295140 | 0001193125-26-161516 |
| 2025-11-06 | 424B4Final prospectus | 333-290793 | 0001193125-25-270066 |
| 2025-10-17 | S-1/AAmendment | 333-290793 | 0001193125-25-242492 |
| 2025-10-09 | S-1Registration filed | 333-290793 | 0001193125-25-235673 |
| 2025-05-14 | DRSDraft made public | 377-08010 | 0000950123-25-005244 |